Endo International (TSX:ENDP) EV-to-Revenue : 3.55 (As of Apr. 26, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Endo International EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Endo International's enterprise value is C$9,624 Mil. Endo International's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$2,710 Mil. Therefore, Endo International's EV-to-Revenue for today is 3.55.

The historical rank and industry rank for Endo International's EV-to-Revenue or its related term are showing as below:

TSX:ENDP' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.43 Med: 2.76 Max: 8.47
Current: -0.38

During the past 13 years, the highest EV-to-Revenue of Endo International was 8.47. The lowest was -0.43. And the median was 2.76.

TSX:ENDP's EV-to-Revenue is ranked better than
99.22% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs TSX:ENDP: -0.38

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-26), Endo International's stock price is C$14.31. Endo International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$11.98. Therefore, Endo International's PS Ratio for today is 1.19.

Endo International EV-to-Revenue Historical Data

The historical data trend for Endo International's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International EV-to-Revenue Chart

Endo International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

2.77

3.03

2.56

-0.43

-0.38

Endo International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															-0.43	-0.40	-0.40	3.18	-0.38

Competitive Comparison of Endo International's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Endo International's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endo International's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo International's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Endo International's EV-to-Revenue falls into.

Endo International EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Endo International's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	9623.967	/	2710.496
	=	3.55

Endo International's current Enterprise Value is C$9,624 Mil.
Endo International's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2,710 Mil.

Endo International (TSX:ENDP) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Endo International's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	14.31	/	11.983
	=	1.19

Endo International's share price for today is C$14.31.
Endo International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$11.98.

Endo International EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Endo International's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo International (TSX:ENDP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (TSX:ENDP) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

ENDPQ:USA EO7:Germany

Address

Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4

Website

https://www.endo.com

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (TSX:ENDP) Headlines

No Headlines